Symptoms start when healthy stop heartburn drugs

Key points
- Even in those without previous heartburn symptoms, the class of heartburn drugs known as proton pump inhibitors can give rise to such symptoms after the drugs are stopped, according to the results of a study appearing in the journal Gastroenterology.
- "It thus seems that the drugs induce the symptoms they are used to treat, which might lead" to dependency on such drugs, co-author Dr.
- Remier and her colleagues studied 120 healthy volunteers, who received 12 weeks of either dummy pills or eight weeks of a proton pump inhibitor esomeprazole followed by four weeks of dummy pills.
- Almost half - 44 percent - people who had no symptoms developed clinically significant heartburn after withdrawing from the therapy at week 9 to week 12, compared with 15 percent in the dummy pill group for the same time period.
Even in those without previous heartburn symptoms, the class of heartburn drugs known as proton pump inhibitors can give rise to such symptoms after the drugs are stopped, according to the results of a study appearing in the journal Gastroenterology.
"It thus seems that the drugs induce the symptoms they are used to treat, which might lead" to dependency on such drugs, co-author Dr. Christina Reimer, from Køge University Hospital, Denmark, told Reuters Health. Such dependency might explain why use of the medications is increasing, she added.
Remier and her colleagues studied 120 healthy volunteers, who received 12 weeks of either dummy pills or eight weeks of a proton pump inhibitor esomeprazole followed by four weeks of dummy pills.
Almost half - 44 percent - people who had no symptoms developed clinically significant heartburn after withdrawing from the therapy at week 9 to week 12, compared with 15 percent in the dummy pill group for the same time period.
The medications are given to a large number of patients, many of whom may not have acid-related sypmtoms, Reimer noted. "I think that our findings challenge this liberal prescription policy and that we as doctors need to be more restrictive in the future," she said.
The authors of an editorial on the study agree. "Efforts should be pursued to try to restrict proton-pump inhibitor therapy use to those likely to derive benefit," write Drs. Kenneth E. L. McColl and Derek Gillen of University of Glasgow, Gardiner Institute, UK.
SOURCE: Gastroenterology, July 2009.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Digestive Health →
NewsDrugs for Postoperative Nausea May Not Help Most Patients
Patients coming out of anesthesia after surgery may experience nausea or vomiting, and are frequently given drugs to prevent this. But the majority of patients won't benefit from these drugs, according to a large new…
20 July 2006
NewsViagra effectively treats urinary tract symptoms associated with prostate enlargement
Viagra (sildenafil citrate), known for improving erectile dysfunction (ED), also effectively treats the prostate and lower urinary tract symptoms (LUTS) associated with prostate enlargement that often occur with ED, a…
22 November 2005
NewsACG Monthly Cimzia Controls Symptoms of Crohn's for 24 Weeks
Monthly injections of an investigational biologic for Crohn's Disease appear to offer relief from symptoms and may induce remission, according to results of a phase III trial presented here today that compared the agent…